Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) reached a new 52-week high on Thursday . The stock traded as high as $14.15 and last traded at $14.14, with a volume of 162324 shares. The stock had previously closed at $14.00.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on RBGLY shares. Royal Bank of Canada reaffirmed an "outperform" rating on shares of Reckitt Benckiser Group in a report on Friday, March 7th. Sanford C. Bernstein raised shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a report on Thursday, June 5th. Two equities research analysts have rated the stock with a hold rating, two have given a buy rating and four have issued a strong buy rating to the company's stock. According to MarketBeat, Reckitt Benckiser Group currently has a consensus rating of "Buy".
View Our Latest Research Report on Reckitt Benckiser Group
Reckitt Benckiser Group Trading Down 1.8%
The company has a debt-to-equity ratio of 0.97, a current ratio of 0.69 and a quick ratio of 0.47. The firm's 50-day simple moving average is $13.18 and its 200 day simple moving average is $12.93.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Read More
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
